References
- HoltkampDKliebensteinJPRRS Costs Industry $664 Million Annually [webpage on the Internet]Pork Checkoff Study2011 Available from: http://www.pork.org/News/1265/PRRSCostsIndustry664Million.aspxAccessed January 26, 2014
- WangXEatonMMayerMPorcine reproductive and respiratory syndrome virus productively infects monocyte-derived dendritic cells and compromises their antigen-presenting abilityArch Virol2007152228930317031757
- NielsenHSOleksiewiczMBForsbergRStadejekTBøtnerAStorgaardTReversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutationsJ Gen Virol200182Pt 61263127211369869
- KimmanTGCornelissenLAMoormannRJRebelJMStockhofe-ZurwiedenNChallenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinologyVaccine200927283704371819464553
- ChadwickSKriegelCAmijiMNanotechnology solutions for mucosal immunizationAdv Drug Deliv Rev2010624–539440719931581
- DevalapallyHChakilamAAmijiMMRole of nanotechnology in pharmaceutical product developmentJ Pharm Sci200796102547256517688284
- UlmerJBValleyURappuoliRVaccine manufacturing: challenges and solutionsNat Biotechnol200624111377138317093488
- MurtaughMPXiaoZZuckermannFImmunological responses of swine to porcine reproductive and respiratory syndrome virus infectionViral Immunol200215453354712513925
- BhavsarMDAmijiMMPolymeric nano- and microparticle technologies for oral gene deliveryExpert Opin Drug Deliv20074319721317489649
- GiriPKKhullerGKIs intranasal vaccination a feasible solution for tuberculosis?Expert Rev Vaccines2008791341135618980538
- McNeilSENanotechnology for the biologistJ Leukoc Biol200578358559415923216
- PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
- GargNKMangalSKhambeteHSharmaPKTyagiRKMucosal delivery of vaccines: role of mucoadhesive/biodegradable polymersRecent Pat Drug Deliv Formul20104211412820380624
- BinjawadagiBDwivediVManickam1CAdjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigsInt J Nanomedicine2014967969424493925
- DwivediVManickamCPattersonRCross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvantVaccine201129234058406621419162
- DwivediVManickamCPattersonRDodsonKWeemanMRenukaradhyaGJIntranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigsVaccine201129234067407621419164
- RenukaradhyaGJDwivediVManickamCBinjawadagiBBenfieldDMucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspectiveAnim Health Res Rev2012131213722717576
- SrivastavaPInteraction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responsesAnnu Rev Immunol20022039542511861608
- WernerGHMaralRFlochFMigliore-SamourDJollèsPAdjuvant and immunostimulating activities of water-soluble substances extracted from Mycobacterium tuberculosis (var. hominis)Biomedicine19752254404524166
- LarsonCLBellJFListRHRibiEWichtWCSymposium on relationship of structure of microorganisms to their immunological properties. ii. host-reactive properties of cell walls and protoplasm from mycobacteriaBacteriol Rev19632734135114097344
- WhiteRGBernstockLJohnsRGLedererEThe influence of components of M. tuberculosis and other Mycobacteria upon antibody production to ovalbuminImmunology195811546613513142
- DwivediVManickamCBinjawadagiBJoyappaDRenukaradhyaGJBiodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigsPLoS One2012712e5179423240064
- DwivediVManickamCBinjawadagiBRenukaradhyaGJPLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigsVet Microbiol20131661–2475823764272
- KimWILeeDSJohnsonWRoofMChaSHYoonKJEffect of genotypic and biotypic differences among PRRS viruses on the serologic assessment of pigs for virus infectionVet Microbiol20071231–311417467931
- TakayamaKSchnoesHKArmstrongELBoyleRWSite of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosisJ Lipid Res1975164308317806645
- JungKAlekseevKPZhangXCheonDSVlasovaANSaifLJAltered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirusJ Virol20078124136811369317942563
- RenukaradhyaGJAlekseevKJungKFangYSaifLJPorcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus in pigsViral Immunol201023545746620883160
- KaiserTJChristopher-HenningsJNelsonEAMeasurement of immunoglobulin G, A and M concentrations in boar seminal plasmaTheriogenology20005471171118411131334
- ZhangLTianXZhouFIntranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivoInt Immunopharmacol20077131732174017996683
- MulupuriPZimmermanJJHermannJAntigen-specific B-cell responses to porcine reproductive and respiratory syndrome virus infectionJ Virol200882135837017942527
- ThompsonALJohnsonBTSempowskiGDMaximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine productionJ Immunol201218862834284622345651
- FerreiraMUKatzinAMThe assessment of antibody affinity distribution by thiocyanate elution: a simple dose-response approachJ Immunol Methods199518722973057499889
- GuoYJSunSHZhangYProtection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccineVaccine20042229–303841384715364430
- AdamACiorbaruRPetitJFLedererEIsolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatisProc Natl Acad Sci U S A19726948518544502937
- AzevedoMSYuanLPoulySCytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirusJ Virol200680137238216352562
- Christopher-HenningsJHollerLDBenfieldDANelsonEADetection and duration of porcine reproductive and respiratory syndrome virus in semen, serum, peripheral blood mononuclear cells, and tissues from Yorkshire, Hampshire, and Landrace boarsJ Vet Diagn Invest200113213314211289209
- CaiHYAlexanderHCarmanSLloydDJosephsonGMaxieMGRestriction fragment length polymorphism of porcine reproductive and respiratory syndrome viruses recovered from Ontario farms, 1998–2000J Vet Diagn Invest200214434334712152819
- FangYKimDYRoppSHeterogeneity in Nsp2 of European-like porcine reproductive and respiratory syndrome viruses isolated in the United StatesVirus Res2004100222923515019241
- ManickamCDwivediVPattersonRPapenfussTRenukaradhyaGJPorcine reproductive and respiratory syndrome virus induces pronounced immune modulatory responses at mucosal tissues in the parental vaccine strain VR2332 infected pigsVet Microbiol20131621687722995873
- DarwichLDíazIMateuECertainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiologyVirus Res20101541–212313220659507
- KamijukuHNagataYJiangXMechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza virusesMucosal Immunol20081320821819079180
- GuillonneauCMinternJDHubertFXCombined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunityProc Natl Acad Sci U S A200910693330333519211791
- OgraPLMucosal immune response to poliovirus vaccines in childhoodRev Infect Dis19846Suppl 2S361S3686740074
- SchmidtACWenzkeDRMcAuliffeJMMucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneJ Virol20027631089109911773385
- ImaokaKMillerCJKubotaMNasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissuesJ Immunol199816111595259589834076
- ManochaMPalPCChitralekhaKTEnhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell targetVaccine20052348–495599561716099080
- RossowKDBenfieldDAGoyalSMNelsonEAChristopher- HenningsJCollinsJEChronological immunohistochemical detection and localization of porcine reproductive and respiratory syndrome virus in gnotobiotic pigsVet Pathol19963355515568885182
- GanterMHenselACellular variables in bronchoalveolar lavage fluids (BALF) in selected healthy pigsRes Vet Sci19976332152179491446
- KugathasanKRoedigerEKSmallCLMcCormickSYangPXingZCD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cellsBMC Immunol200894818700962
- PlagemannPGRowlandRRCafrunyWAPolyclonal hypergammaglobulinemia and formation of hydrophobic immune complexes in porcine reproductive and respiratory syndrome virus-infected and uninfected pigsViral Immunol200518113814715802958
- ButlerJEWertzNWeberPLagerKMPorcine reproductive and respiratory syndrome virus subverts repertoire development by proliferation of germline-encoded B cells of all isotypes bearing hydrophobic heavy chain CDR3J Immunol200818042347235618250444
- KimHKimHKJungJHThe assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methodsVirol J2011832321703032
- VanheeMDelputtePLDelrueIGeldhofMFNauwynckHJDevelopment of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodiesVet Res20094066319674539
- RajapaksaTEBennettKMHamerMLytleCRodgersVGLoDDIntranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strengthJ Biol Chem201028531237392374620511224
- AraujoLLöbenbergRKreuterJInfluence of the surfactant concentration on the body distribution of nanoparticlesJ Drug Target19996537338510342385
- HeegaardPMDedieuLJohnsonNAdjuvants and delivery systems in veterinary vaccinology: current state and future developmentsArch Virol2011156218320221170730
- HarmalaLAIngulliEGCurtsingerJMThe adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivoJ Immunol2002169105622562912421941
- BansalKElluruSRNarayanaYPE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cellsJ Immunol201018473495350420176745
- LyckeNRecent progress in mucosal vaccine development: potential and limitationsNat Rev Immunol201212859260522828912
- BinjawadagiBDwivediVManickamCTorrellesJBRenukaradhyaGJIntranasal delivery of an adjuvanted modified live porcine reproductive and respiratory syndrome virus vaccine reduces ROS productionViral Immunol201124647548222111597
- DwivediVManickamCBinjawadagiBLinharesDMurtaughMPRenukaradhyaGJEvaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditionsVirol J201294522340040
- ManickamCDwivediVMillerJPapenfussTRenukaradhyaGJMycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigsViral Immunol201326110210823308386
- AmorijJPKerstenGFSalujaVTowards tailored vaccine delivery: needs, challenges and perspectivesJ Control Release2012161236337622245687
- BachmannMFJenningsGTVaccine delivery: a matter of size, geometry, kinetics and molecular patternsNat Rev Immunol2010101178779620948547
- LopezOJOsorioFARole of neutralizing antibodies in PRRSV protective immunityVet Immunol Immunopathol2004102315516315507302
- SpellbergBEdwardsJEType 1/Type 2 immunity in infectious diseasesClin Infect Dis20013217610211118387
- SchlieheCRedaelliCEngelhardtSCD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivoJ Immunol201118752112212121795597
- DementoSLCuiWCriscioneJMRole of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotypeBiomaterials201233194957496422484047
- MaWChenMKaushalSPLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responsesInt J Nanomedicine201271475148722619507
- SansonettiPJDi SantoJPDebugging how bacteria manipulate the immune responseImmunity200726214916117307704
- OlinMRBatistaLXiaoZGammadelta lymphocyte response to porcine reproductive and respiratory syndrome virusViral Immunol200518349049916212527
- ChongCSCaoMWongWWEnhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine deliveryJ Control Release20051021859915653136
- ZimmermanJJBenfieldDDeeSPorcine reproductive and respiratory syndrome virus (Porcine Arterivirus)ZimmermanJJKarrikerLARamirezASchwartzKJStevensonGWDiseases of Swine, Tenth EditionWiley-BlackwellHoboken, NJ, USA2012461486
- WillsRWZimmermanJJYoonKJPorcine reproductive and respiratory syndrome virus: a persistent infectionVet Microbiol1997551–42312409220618